Javelin Pharmaceuticals, Inc. , a leading developer of novel acute care pain products, commented on the tender offer extension by Hospira, Inc.
127668
Javelin Pharmaceuticals, Inc. comments on tender offer extension by Hospira
81525
Michaels commences Tender Offer
133645
Wockhardt received tentative approval for the Fexofenadine Hydrochloride
70188
Pharmac to extend financial help to asthma drug
5493
Dufenergy may sell Italian commercial arm
140240
Price escalation likely to create acute medicines shortage
151613
Agrolizing announces tender
139139
Health region responds to charges
75604
FDA approves expanded indication for cardiac resynchronization therapy
19743
Boston Scientific assigned patent for drug delivery
79421
Medfusion acquires Medem's iHealth services
115259
Sanofi-aventis extends tender offer for all outstanding shares of Genzyme
84656
MedeAnalytics receives patent pending for charge capture
155461
Macklowe reaches extension agreements with lenders
1365
New drug strategy master plan being crafted --
157333
Molecular Insight receives 10th extension of waiver agreement with bond holders
2144
Holcim enters into loan facility agreement